James Roach
James Roach is an experienced NHS director having held roles in hospitals, clinical commissioning groups and in joint roles with social care. James runs Conclusio Limited, developing innovative solutions in health and care systems in UK and China.
Latest articles
Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS
The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Primary care networks and mental health services post COVID-19
Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Accelerated use of electronic prescribing
Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
COVID-19: Pharma on the frontline
Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
ABPI Code and promotional emails
Dr Rina Newton, Managing Director of CompliMed, looks at the considerations relating to the ABPI Code of Practice and promotional emails. In the June issue...